Motixafortide

Motixafortide API

Motixafortide yog ib qho hluavtaws CXCR4 antagonist peptide tsim los txhawb cov kab mob hematopoietic qia hlwb (HSCs) rau kev hloov pauv hauv autologous thiab tseem tau kawm hauv oncology thiab immunotherapy.

Mechanism & Kev Tshawb Fawb:

Motixafortide thaiv cov CXCR4-SDF-1 axis, ua rau:
Ceev cov qia cell mobilization rau hauv cov ntshav peripheral
Txhim kho lub cev tiv thaiv kab mob kev lag luam thiab cov qog infiltration
Muaj peev xwm sib koom ua ke nrog checkpoint inhibitors thiab chemotherapy

Nws tau ua kom pom cov txiaj ntsig zoo ntawm cov qia cell piv rau cov neeg mob uas twb muaj lawm hauv kev sim tshuaj.
API Nta (Gentolex Group):

High-purity hluavtaws peptide
GMP zoo li cov qauv tsim khoom
Haum rau kev txhaj tshuaj formulations

Motixafortide API txhawb nqa kev tshawb fawb qib siab hauv kev kho mob qia cell thiab kho mob qog noj ntshav.